This site is intended for healthcare professionals only
LoginRegister
Eli Lilly to acquire SiteOne Therapeutics in USD 1 billion dealEli Lilly announces transitions in executive leadership
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in IndiaZealand Pharma announces closing of collaboration, license agreement with Roche
Telangana NSQ DrugsNo Medicine Shortage: AIOCD Appeals to Chemists to Stay Alert and Serve as 'Jan Swasthya Rakshak'
Delhi HC Declines Stay on Medipol Pharmas Debarment Over Substandard Clarithromycin, Noscapine, Appoints ArbitratorDelhi HC Clears Mankind Prime Labs' CROSSRELIEF Trademark for Registration
Novartis ianalumab Phase III trial meets primary endpoint in immune thrombocytopeniaCDSCO Panel Approves Novartis' Protocol Amendment proposal for Iptacopan Clinical study in Kidney...
Dr Reddys Labs reappoints G V Prasad as Co-Chairman, MDDr Reddy's Labs reappoints G V Prasad as Co-Chairman, MD
acquisitionTPG to acquire 35% stake in SCHOTT Poonawalla from SII
Sun Pharma, Alembic and 1 other recall productsFDC recalls more than 60000 bottles of glaucoma medication in US
Dr Reddys Labs Switzerland incorporates new wholly-owned arm in VietnamDr Reddy's Labs Switzerland incorporates new wholly-owned arm in Vietnam
Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: PharmatracPost-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac
NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; DetailsNPPA fixes retail prices for Otsuka Pharmaceutical's 3 formulations
CDSCO Launches One-Year Online Dual Use NOC System for Bulk Drug ImportsCDSCO issues Revised Export NOC Guidance document for Manufacture of Unapproved, Approved New Drugs
X